FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

The Harvard Drug Group Doxycycline Hyclate Tablets Recall

Doxycycline Hyclate Tablets, USP, 100 mg, packaged in a) 3x10 unit dose cartons (NDC 09…

The Harvard Drug Group · Livonia, MI

Risk level
Class II
Reported by FDA
Jun 10, 2020
Recall ID
D-1288-2020
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Doxycycline Hyclate Tablets starting May 22, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1288-2020 on Jun 10, 2020. Reason: Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.

Product description

Doxycycline Hyclate Tablets, USP, 100 mg, packaged in a) 3x10 unit dose cartons (NDC 0904-0430-04) and b) 5 x 10 unit dose carton (NDC 0904-0430-06), Mfd. by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152.

Lot numbers, UPCs & expiration codes

Lot #: a) R00828D, Exp. date 08/2020, b) R00732D, Exp. date 05/2020; R00783D, Exp. date 06/2020; R00827D, Exp. date 08/2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1288-2020
Classification
Class II
Status
Terminated
Recall initiated
May 22, 2020
FDA report date
Jun 10, 2020
Quantity
16,443 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group

Original FDA data

Every field from FDA enforcement report D-1288-2020, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
85757
Address
17177 N Laurel Park Dr Ste 233
Code information
Lot #: a) R00828D, Exp. date 08/2020, b) R00732D, Exp. date 05/2020; R00783D, Exp. date 06/2020; R00827D, Exp. date 08/2020
Postal code
48152-3951
Report date
Jun 10, 2020
Product type
Drugs
Recall number
D-1288-2020
Classification
Class II
Recalling firm
The Harvard Drug Group
Product quantity
16,443 cartons
Termination date
Oct 2, 2022
Reason for recall
Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Doxycycline Hyclate Tablets, USP, 100 mg, packaged in a) 3x10 unit dose cartons (NDC 0904-0430-04) and b) 5 x 10 unit dose carton (NDC 0904-0430-06), Mfd. by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152.
Distribution pattern
Nationwide within the United States
Recall initiation date
May 22, 2020
Initial firm notification
Letter
Center classification date
Jun 4, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1288-2020, published Jun 10, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls